Connection
Thomas Flaig to Vascular Endothelial Growth Factors
This is a "connection" page, showing publications Thomas Flaig has written about Vascular Endothelial Growth Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.308 |
|
|
|
-
Flaig TW, Su LJ, McCoach C, Li Y, Raben D, Varella-Garcia M, Bemis LT. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose- and sequence-dependent manner. BJU Int. 2009 Jun; 103(12):1729-37.
Score: 0.308